CP 55,940
CP 55,940 structure
|
Common Name | CP 55,940 | ||
|---|---|---|---|---|
| CAS Number | 83002-04-4 | Molecular Weight | 376.573 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 494.4±45.0 °C at 760 mmHg | |
| Molecular Formula | C24H40O3 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 209.2±23.3 °C | |
Use of CP 55,940CP-55940 is a non-selective cannabinoid receptor agonist with Ki values of 0.58 and 0.69 nM for human recombinant CB1 and CB2, respectively. |
| Name | CP 55,940,(-)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol |
|---|---|
| Synonym | More Synonyms |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 494.4±45.0 °C at 760 mmHg |
| Molecular Formula | C24H40O3 |
| Molecular Weight | 376.573 |
| Flash Point | 209.2±23.3 °C |
| Exact Mass | 376.297760 |
| PSA | 60.69000 |
| LogP | 5.97 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.526 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
|
Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.
J. Pharmacol. Exp. Ther. 351(2) , 383-9, (2014) Cannabinoid receptor agonists, such as Δ(9)-tetrahydrocannabinol (Δ(9)-THC), enhance the antinociceptive effects of μ-opioid receptor agonists, which suggests that combining cannabinoids with opioids ... |
|
|
Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration.
Am. J. Pathol. 298 , C993-1005, (2010) We recently demonstrated that thapsigargin-induced passive store depletion activates Ca(2+) entry in vascular smooth muscle cells (VSMC) through stromal interaction molecule 1 (STIM1)/Orai1, independe... |
|
|
Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay.
J. Biomol. Screen. 14 , 49-58, (2009) The authors have characterized a set of cannabinoid CB(2) receptor ligands, including triaryl bis sulfone inverse agonists, in a cell-based receptor/beta-arrestin interaction assay (DiscoveRx PathHunt... |
| Phenol, 5-(1,1-dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]- |
| CP 55,940 |
| Sodium phosphate dibasic |
| MFCD00673965 |
| 2-[(1R,2R,5R)-5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyl-2-octanyl)phenol |
| UNII:8YX8JK1BQG |
| 2-[(1r,2r,5r)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol |